Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: A study using combined pH-impedance monitoring

Journal of Gastroenterology

Volumn 44, Issue 7, 2009, Pages 708-712

  Iwakiri, Katsuhiko ^a   Kawami, Noriyuki ^a   Sano, Hirohito ^a   Tanaka, Yuriko ^a   Umezawa, Mariko ^a   Kotoyori, Makoto ^a   Hoshihara, Yoshio ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acid reflux; Impedance monitoring; Non acid reflux; Non erosive reflux disease; Persistent heartburn

Indexed keywords

RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DOSE RESPONSE; DYSPHAGIA; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; HEARTBURN; HUMAN; IMPEDANCE; JAPANESE; LOWER ESOPHAGUS SPHINCTER; MALE; NON ACID REFLUX DISEASE; NON EROSIVE REFLUX DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; THORAX PAIN; THROAT DISEASE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ELECTRIC IMPEDANCE; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS;

EID: 68149119157     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0070-6     Document Type: Article

References (15)

1. Richter JE, Bockenek W. Oral pantprazole for erosive esophagitis: A placebo-controlled randomized clinical trial. Pantoprazole US GERD study group. Am J Gastroenterol. 2000;95:3071-80.
2. Bardhan KD, Hawkey CJ, Long RG, Morgan AG, Wormsley KG, Moules IK, et al. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group. Aliment Pharmacol Ther. 1995;9:145-51.
3. Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996;91:1749-57.
4. Sharma VK, Leontiadis GI, Howden CW. Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. Aliment Pharmacol Ther. 2001;15:227-31.
5. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2:656-64.
6. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: Proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther. 2005;22:79-94.
7. Fass R. Persistent heartburn in a patient on proton-pump inhibitor. Clin Gastroenterol Hepatol. 2008;6:393-400.
8. Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003;37:206-15.
9. Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: A multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037-43.
10. Sifrim D, Castell D, Dent J, Kahrilus PJ. Gastro-oesophageal reflux monitoring: Review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024-31.
11. Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the in the distal esophagus. Am J Gastroenterol. 1974;62:323-32.
12. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398-402.
13. Balaban DH, Yamamoto Y, Liu J, Pehlivanov N, Wisniewski R, DeSilvey D, et al. Sustained esophageal contraction: A marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology. 1999;116:29-37.
14. Kinoshita Y, Kobayashi T, Kato M, Asahina K, Haruma K, Shimatani T, et al. The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. J Gastroenterol. 2006;41:554-61.
15. Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Nakamura M, et al. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: A crossover comparative study in homozygous extensive metabolizers of cytochrome P4502C19. Clin Pharmacol Ther. 2006;79:144-52.